The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

The recent approval of lenacapavir could change the way that clinicians approach both treating and preventing HIV in those at risk, as long as the treatment can get into their hands.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The country has seen historic reductions in uninsured rates and improvements in affordability since the implementation of the ...

The Choose Medicare Act would establish a Medicare Part E that would give employers and the general public the ability to opt ...

Early circulating tumor DNA (ctDNA) changes predict survival in mismatch repair or microsatellite instability–high (dMMR/MSI-H) metastatic colorectal cancer (mCRC) treated with immune checkpoint ...

Patients with type 2 diabetes had a lower risk of glaucoma when they used glucagon-like peptide 1 (GLP-1) receptor agonists across multiple studies.

The recent approval of garadacimab can help to treat patients with hereditary angioedema (HAE) along with sebetralstat, which is awaiting FDA approval, explains Timothy Craig, DO, Penn State Health.

CEPHEUS trial lead investigator Saad Z. Usmani, MD, MBA, FACP, FASCO, explains how the trial both builds on current knowledge of newly diagnosed multiple myeloma and how transplant-ineligible status ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Panelists discuss several promising new agents for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including an LPA1 receptor antagonist showing lung function ...